Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
      • Neuroimmunology: To Sense and Protect
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

IL-17 Receptor Signaling Is Required to Control Polymicrobial Sepsis

Andressa Freitas, José C. Alves-Filho, Tatiana Victoni, Thomas Secher, Henrique P. Lemos, Fabiane Sônego, Fernando Q. Cunha and Bernhard Ryffel
J Immunol June 15, 2009, 182 (12) 7846-7854; DOI: https://doi.org/10.4049/jimmunol.0803039
Andressa Freitas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
José C. Alves-Filho
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tatiana Victoni
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Secher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henrique P. Lemos
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fabiane Sônego
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fernando Q. Cunha
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernhard Ryffel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Sepsis is a systemic inflammatory response resulting from the inability of the host to contain the infection locally. Previously, we demonstrated that during severe sepsis there is a marked failure of neutrophil migration to the infection site, which contributes to dissemination of infection, resulting in high mortality. IL-17 plays an important role in neutrophil recruitment. Herein, we investigated the role of IL-17R signaling in polymicrobial sepsis induced by cecal ligation and puncture (CLP). It was observed that IL-17R-deficient mice, subjected to CLP-induced non-severe sepsis, show reduced neutrophil recruitment into the peritoneal cavity, spread of infection, and increased systemic inflammatory response as compared with C57BL/6 littermates. As a consequence, the mice showed an increased mortality rate. The ability of IL-17 to induce neutrophil migration was demonstrated in vivo and in vitro. Beside its role in neutrophil recruitment to the infection focus, IL-17 enhanced the microbicidal activity of the migrating neutrophils by a mechanism dependent on NO. Therefore, IL-17 plays a critical role in host protection during polymicrobial sepsis.

Neutrophils are the major leukocytes promptly recruited to the inflamed site in response to infection or tissue injury. These cells are ideally suited to the elimination of pathogenic bacteria due to their capability of phagocytosis, releasing the stores of granular lytic enzymes and antimicrobial polypeptides into the phagolysosome (1). In this way, migrating neutrophils may control bacterial growth and, consequently, prevent bacterial dissemination and death (2, 3, 4, 5, 6, 7, 8). However, once the host fails to restrict the pathogens to a localized area, they and/or their products may spread systemically, resulting in an overproduction of cytokines/chemokines, systemic inflammatory response syndrome, septic shock, and death (9, 10, 11).

In fact, the importance of neutrophil recruitment to the infection focus in the development of sepsis has been clearly demonstrated in experimental and human sepsis by our laboratory. We showed that the failure of neutrophil migration is observed in severe polymicrobial sepsis (5, 7, 12), Gram negative or positive (6, 8). The impairment of neutrophil migration was associated with a decrease in the rolling and adhesion of neutrophils on endothelial cells, leading to a failure of bacterial clearance in the infection focus, increased number of bacteria in blood, high levels of circulating cytokines/chemokines, and mortality. Conversely, in mice subjected to non-severe sepsis, in which neutrophil migration failure was not observed, bacterial infection was restricted to the peritoneal cavity and, consequently, no mortality was observed (5, 6, 7, 8, 12). Furthermore, neutrophils obtained from septic patients showed reduced chemotaxis in response to IL-8, leukotriene B4, and fMLP, and the intensity of the reduction of neutrophil chemotaxis correlated with the severity of the sepsis (13, 14). The mechanisms involved in neutrophil migration failure are not completely understood. However, it is known that systemic activation of TLRs by bacteria and/or their products results in excessive production of circulating cytokines/chemokines which stimulate the expression of inducible NO synthase, leading to high amounts of NO, which in turn result in the reduction of neutrophil/endothelium interaction and chemotaxis (5, 6, 8, 14, 15, 16, 17).

IL-17 is the founding member of a new multimember cytokine family consisting of IL-17 (IL-17A) and IL-17B to IL-17F (18, 19, 20, 21, 22, 23, 24, 25). IL-17 (IL-17A) is a proinflammatory cytokine produced mainly by the memory T cells known as Th17 (18, 26, 27, 28, 29), a Th cell lineage distinct from Th1 and Th2 cells, which is negatively regulated by IFN-γ and IL-4 (30, 31). IL-17 plays a particularly significant role in regulating neutrophil recruitment and granulopoiesis. IL-17 up-regulates G-CSF and overexpression of IL-17 causes neutrophilia in mice (32). In addition, it has been demonstrated that IL-17 is involved in neutrophil recruitment via the production of several cytokines and CXC chemokines such as Gro-α (keratinocyte-derived chemokine (KC),3 CXCL1), LIX (CXCL5), and MIP-2 (CXCL2) (33, 34, 35, 36, 37). Recent reports indicate that IL-17 is critical in the clearance of several pathogens, including Klebsiella pneumoniae, Escherichia coli, Candida albicans, and Toxoplasma gondii (35, 38, 39). It was demonstrated that IL-17R-deficient mice showed an impaired host defense against K. pneumoniae, which was associated with a marked reduction in neutrophil recruitment to the lung (35). Moreover, it was also shown that the production of IL-17 after i.p. inoculation of E. coli is critical for the local infiltration of neutrophils and control of bacteria growth (40). On the other hand, other authors demonstrated that the blockage of IL-17A was protective in cecal ligation and puncture (CLP)-induced sepsis. These authors associated the protective effects of IL-17A blockade with a reduction in the levels of bacteremia and of systemic proinflammatory cytokines and chemokines (41).

Therefore, in the present study using IL-17R-deficient mice, we investigated the role of IL-17R signaling in neutrophil migration to the infection focus and in the outcome of polymicrobial sepsis induced by CLP. We found that the absence of IL-17R signaling results in an impairment of neutrophil migration toward the infection focus followed by bacteremia and an increase in systemic inflammatory response, resulting in high mortality. Furthermore, IL-17 increased the microbicidal activity of neutrophils, by a NO-dependent mechanism. Thus, our data provide clear evidence for a critical role of IL-17R signaling in the protective response against polymicrobial sepsis.

Materials and Methods

Mice

Adult male C57BL/6 wild-type (WT) mice were bred in a specific pathogen-free animal facility at the Transgenose Institut (Centre National de la Recherche Scientifique, Orleans, France). Adult male IL-17R knockout (KO) mice were on a C57BL/6 genetic background, as described previously (35), and provided by Amgen. Mice were maintained in a temperature-controlled (23°C) facility with a strict 12-h light-dark cycle and were given free access to food and water. The experiments were performed with gender-matched mice ages 10–12 wk. All animal experiments complied with the French government’s ethical and animal experiment regulations.

Drugs and reagents

Percoll, RPMI 1640, HBSS medium, and aminoguanidine were purchased from Sigma-Aldrich. Aminoguanidine was dissolved in saline. IL-17 was purchased from R&D Systems.

Induction of sepsis using CLP model

Sepsis was induced by the CLP model (42). Briefly, mice were anesthetized with ketamine and xylazine diluted in PBS (1.25 mg/ml ketamine:0.5 mg/ml xylazine) by the i.p. administration of 200 μl, and a 1-cm midline incision was made on the anterior abdomen. The cecum was exposed and ligated below the ileocecal junction without causing bowel obstruction. A triple puncture was made using a 30-gauge needle to induce non-severe septic injury (NS-CLP) and a double puncture with an 18-gauge needle to induce severe septic injury (S-CLP). Pressure was applied (the cecum was squeezed) to allow cecum contents to be expressed through the punctures. The cecum was placed back in the abdominal cavity and the peritoneal wall and skin incision were closed. All animals received 1 ml of saline s.c. immediately after the surgery. Sham-operated animals (controls) underwent identical laparotomy but without cecum ligation or puncture.

The survival rates of animals were observed every 12 h up to 7 days after surgery.

Determination of neutrophil migration into peritoneal cavity

Mice were killed 6 h after sham operation or CLP surgery, and the cells present in the peritoneal cavity were harvested by introducing 1.5 ml of PBS/EDTA (1 mM). Moreover, neutrophil migration was assessed 6 h after IL-17 i.p. administration (3–30 ng/cavity; R&D Systems) in C57BL/6 mice. Total cell counts were performed using a Neubauer chamber. Differential cell counts were conducted on cytocentrifuge slides (cytospin at 700 rpm for 10 min at room temperature) stained with Diff-Quik (Merz & Dade). Differential counts were made under oil immersion microscopy, and 100 cells were counted for the determination of the percentage of neutrophils present in the peritoneal cavity. The results are expressed as means ± SEM of the neutrophil number per cavity.

Bacterial counts in the peritoneal exudate and in blood

The bacterial count was determined 6 h after CLP surgery in the peritoneal exudate and in blood of mice as previously described (43). In brief, mice were anesthetized i.p. with ketamine and xylazine diluted in PBS, and peritoneal exudate and blood were collected under sterile conditions. Aliquots of serial dilutions of these samples were plated on brain-heart infusion (BHI) agar plates (Biovalley). Plates were incubated at 37°C and 5% CO2 and CFU were counted after 18 h. The results are expressed as median log of CFU per ml of peritoneal exudate or blood.

Effect of IL-17 in the microbicidal activity of neutrophils

Cecal bacteria isolation.

For the killing assay, bacteria were isolated from the cecum of WT mice. Briefly, the cecum contents of three mice were removed, diluted in PBS, and filtered through sterile gauze. An aliquot of cecal content suspension was diluted in BHI medium (Difco Laboratories) and incubated for 20 h at 37°C and 5% CO2. The suspension was centrifuged (10 min, 2000 × g) and washed twice with PBS. The bacterial suspension was lyophilized (model CT 110; Hetovac) and stored at −70°C. All steps were performed in sterile conditions. For bacterial counts, the lyophilized contents were diluted in BHI medium, homogenized, and incubated for 20 h at 37°C. The bacterial suspension was then centrifuged (10 min, 2000 × g) and the pellet was washed twice with PBS and resuspended in 10 ml of PBS. The number of CFU in the suspension was determined through serial log dilutions and plating on Mueller-Hinton agar dishes (Difco Laboratories). CFU were counted after 18 h and the results are expressed as the log CFU/ml.

Isolation of neutrophils.

WT mice were injected i.p. with thioglycolate (3%) to obtain peritoneal neutrophils. The peritoneal cells were harvested 6 h later by washing the peritoneal cavities with RPMI 1640 medium. Cell viability (trypan blue exclusion) was >98% and the cell population consisted of macrophages and neutrophils, with the latter representing >85% of total leukocytes.

Bacterial killing by neutrophils.

The isolated WT and IL-17R KO neutrophils (1 × 106/ml) were incubated in Eppendorf tubes for 1 h at 37°C and 5% CO2 in antibiotic-free RPMI 1640 with RPMI 1640 (control), 100 ng/ml IL-17, or 300 ng/ml IL-17. In addition, neutrophils from WT mice were incubated with aminoguanidine (AG; 300 μM), an inhibitor of NO synthase, or with IL-17 (100 ng/ml) plus AG (300 μM). Afterward, the bacterial suspension (2 × 106/ml) was added to the neutrophil culture followed by incubation for 3 h at 37°C with mild shaking. As control, the bacterial suspension was incubated in the same experimental condition in the absence of neutrophils. At the end of these incubation times, the tubes were centrifuged (400 × g) and the pellet was lysed in 0.2% Triton X-100. Bacterial viability was assessed by serial log dilutions and plating on Mueller-Hinton agar dishes (Difco Laboratories). CFU were counted after 18 h and the results expressed as number of viable bacteria (log CFU/ml).

Determination of cytokine and chemokine levels

The cytokine and chemokine levels were detected in peritoneal exudate and in serum of mice, 6 h after CLP surgery, by ELISA according to the recommendations of the manufacturer (with detection limits in pg/ml). TNF-α, MIP-2, KC, and IL-17 were all purchased from R&D Systems. The results are expressed as pg/ml of peritoneal exudate or blood.

Leukogram

Animals were anesthetized with ketamine and xylazine and a sample of blood (diluted in EDTA) was collected 6 h after sepsis induction. Total counts were performed using a Neubauer chamber. Differential cell counts were conducted on cytocentrifuge slides (cytospin at 700 rpm for 10 min at room temperature) stained with Diff-Quik (Merz & Dade). Differential counts were performed under oil immersion microscopy, where 100 cells were counted for the determination of the percentage of neutrophils present in blood. The results are expressed as means ± SEM of the neutrophil number per ml.

Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) activity

The levels of AST and ALT (U/ml) were measured in the serum of mice 6 h after surgery as biochemical indicators of liver injury. The determinations were made using commercial colorimetric kits (Labtest). The results are expressed as means ± SEM.

Neutrophil isolation and chemotaxis

C57BL/6 mice were sacrificed by cervical dislocation. Bone marrow neutrophils were isolated as previously described (44). A modified Boyden chamber assay to examine the neutrophil chemoattractant response to IL-17 was performed using a 48-well microchamber (NeuroProbe). The stimulus IL-17 was diluted in RPMI 1640 and RPMI 1640 alone was used as a negative control. The stimuli and negative control were added to the lower chambers of the apparatus. A 5-μm pore polycarbonate membrane (NeuroProbe) was placed between the upper and lower chambers and 5 × 104 cells in a volume of 50 μl were added to the top chambers of the apparatus. Cells were allowed to migrate into the membrane for 1 h per treatment at 37°C with 5% CO2. Following incubation, the chamber was disassembled and the membrane was scraped and washed in PBS to remove nonadherent cells before being fixed in methanol and stained using the Diff-Quik system (Dade Behring). Each well-associated membrane area was scored using light microscopy to count the intact cells present in five random fields. The results were expressed as the number of neutrophils per field.

Statistical analysis

The data (except for the survival curves and bacterial counts) were reported as the means ± SEM of values obtained from two different experiments. The means of different treatments were compared by ANOVA followed by Bonferroni’s t test for unpaired values (GraphPad Prism Software version 3). Bacterial counts were reported as median log CFU and were analyzed by the Mann-Whitney U test (GraphPad Prism Software version 3). The neutrophil chemotaxis data were analyzed by ANOVA with Tukey’s correction (GraphPad Prism Software version 3). The survival rate was expressed as the percentage of live animals, and the Mantel-Cox log rank test was used to determine differences between survival curves (GraphPad Prism Software version 3). A p value of 0.05 or less was considered significant.

Results

IL-17R signaling is required for resistance against polymicrobial sepsis

Initial experiments were designed to determine the involvement of IL-17R signaling in the outcome of polymicrobial sepsis. For this purpose, IL-17R gene-deficient (IL-17R KO) mice were subjected to NS-CLP or S-CLP polymicrobial sepsis using the CLP model. As shown in Fig. 1⇓A, IL-17R-deficient mice displayed a significant reduction in survival rate following NS-CLP. At 60 h after NS-CLP, 100% of WT mice were alive compared with 80% in IL-17R KO mice. The detrimental effect of the absence of IL-17R signaling increased thereafter. On the third and fourth days after NS-CLP, the survival rates in WT mice stayed at 100%, whereas 60 and 40% survival rates were observed in IL-17R KO mice, respectively. With regard to S-CLP, both WT and IL-17R KO mice showed almost the same survival rate curves during the observation period. At 7 days after CLP, both groups had survival rates of only 20%. The sham-operated mice (WT and IL-17R KO) survived for the whole period of observation.

FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

IL-17R signaling is required for resistance against polymicrobial sepsis. IL-17R KO mice and their respective WT control were subjected to sham surgery, NS-CLP, or S-CLP sepsis induced using the CLP model. A, The survival rates of animals were determined every 12 h until 7 days after sepsis induction. The results are expressed as percent for 10 animals per experimental group. ∗, p < 0.05 compared with WT mice subjected to NS-CLP (Mantel-Cox log rank test). B, Neutrophil migration into the peritoneal cavity of mice was performed 6 h after CLP surgery. The results are expressed as means ± SEM (n = 10 animals/experimental group). ∗, p < 0.05 compared with sham group; #, p < 0.05 compared with WT mice subjected to NS-CLP (ANOVA, followed by Bonferroni’s test). C, IL-17 concentrations (pg/ml) were quantified in the peritoneal exudates of WT mice subjected to sham surgery or NS-CLP, 6 h after CLP, as described in Materials and Methods. The results are expressed as means ± SEM of five animals in each group. ∗, p < 0.05 compared with sham group (Student’s t test).

To identify the mechanisms underlying the susceptibility of IL-17R KO mice to NS-CLP, we investigated the neutrophil recruitment to the peritoneal cavity after sepsis induction. Fig. 1⇑B shows that the WT animals subjected to NS-CLP showed a marked neutrophil migration into the peritoneal cavity 6 h after surgery, whereas IL-17R KO mice subjected to the same procedure displayed a significant reduction in neutrophil migration. Confirming previous results (4, 5, 7, 8, 12), Fig. 1⇑B also shows that WT animals subjected to S-CLP failed to recruit neutrophils to the infection focus. Although it was not statistically significant, the IL-17R-deficient mice subjected to S-CLP showed a greater failure of neutrophil recruitment compared with WT mice. It was also observed that compared with sham-operated mice, WT animals subjected to NS-CLP produced significant amounts of IL-17 at the infection focus (Fig. 1⇑C). Taken together, these results demonstrate that IL-17A is produced in CLP sepsis and IL-17R signaling plays a critical role in neutrophil recruitment to the infection focus and consequent host survival.

IL-17R KO mice subjected to NS-CLP had increased bacteria levels in peritoneal exudate and in blood

To associate the migration of neutrophils with the control of infection focus, we examined the capacity of IL-17R-defective mice to control bacterial dissemination. For this, we determined the bacterial load in the peritoneal exudate and in blood 6 h after non-severe sepsis induction. As shown in Fig. 2⇓, IL-17 R KO mice subjected to NS-CLP had a marked increase in the amount of bacteria in peritoneal exudate and in blood compared with WT mice also subjected to NS-CLP. The load of bacteria in peritoneal exudates and in blood found in IL-17R KO animals subjected to NS-CLP were similar to those observed in WT mice subjected to severe sepsis. Therefore, the absence of IL-17R signaling in a model of non-severe sepsis results in reduced neutrophil recruitment to the infection focus and loss of infection control.

FIGURE 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2.

IL-17R-deficient mice subjected to NS-CLP showed increased amounts of bacteria in peritoneal exudate and in blood. IL-17R KO and their respective WT controls were subjected to sham surgery, NS-CLP, or S-CLP sepsis induced by the CLP model. Bacterial counts in the peritoneal exudate (A) and in blood (B) were performed 6 h after sepsis induction. The results are expressed as the median log of CFU/ml peritoneal exudate or blood (n = 10 animals/experimental group). ∗, p < 0.05 compared with sham group; #, p < 0.05 compared with WT mice subjected to NS-CLP; ∗∗, p < 0.05 compared with IL-17R KO mice subjected to NS-CLP; and §, p < 0.05 compared with WT mice subjected to S-CLP (Mann-Whitney U test).

IL-17 affects neutrophil microbicidal activity

In addition, we explored whether IL-17, besides having the ability to recruit neutrophils to the infection focus, also increases the microbicidal activity of this leukocyte subtype. As shown in Fig. 3⇓, neutrophils harvested from IL-17R-defective mice demonstrated reduced killing activity compared with WT neutrophils, suggesting a physiological role of IL-17R signaling in the microbicidal activity of neutrophils. Moreover, WT neutrophils incubated with IL-17 (100 or 300 ng/ml) for 3 h showed a significant increase in bacterial killing compared with WT neutrophils incubated with RPMI 1640 alone. However, the IL-17 effect was not observed when neutrophils were harvested from IL-17R-defective mice (Fig. 3⇓). Furthermore, the potentiating effect of IL-17 on neutrophil killing capacity was mediated by NO, since this effect was blocked by coincubation of IL-17 with AG (300 μM), a NO synthase inhibitor (Fig. 3⇓). Taken together, our results demonstrated that during non-severe sepsis, besides the chemotactic activity, IL-17 also enhances the microbicidal activity of neutrophils.

FIGURE 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3.

IL-17 increases neutrophil microbicidal activity. Neutrophils harvested from WT and IL-17R KO mice were incubated in vitro for 1 h at 37°C and 5% CO2 with antibiotic-free RPMI 1640, 100 ng/ml IL-17, or 300 ng/ml IL-17. Moreover, neutrophils from WT mice were incubated with AG (300 μM) or IL-17 (100 ng/ml) plus AG (300 μM). Neutrophil killing was evaluated by incubating these neutrophils (1 × 106/ml) with cecal bacteria (2 × 106/ml) at 37°C for 3 h with mild shaking as described in Materials and Methods. The number of replicates ranged between 4 and 15. The results are expressed as the number of viable ingested bacteria (log CFU/ml). ∗, p < 0.05 compared with bacteria incubated without neutrophils; #, p < 0.05 compared with WT neutrophils incubated with medium plus bacteria; ∗∗, p < 0.05 compared with WT neutrophils incubated with IL-17 (100 ng/ml) plus bacteria; and ##, p < 0.05 compared with WT neutrophils incubated with IL-17 (300 ng/ml) plus bacteria (Mann-Whitney U test).

IL-17R signaling is required for the control of systemic inflammatory response

To further extend the importance of IL-17R signaling in the outcome of sepsis, we evaluated the systemic inflammatory response in mice subjected to sepsis. We therefore determined the systemic concentrations of TNF-α (index of systemic cytokine production) and the hepatic enzymes AST and ALT (index of organ dysfunction). As shown in Fig. 4⇓A, the serum levels of TNF-α 6 h after surgery were significantly increased in IL-17R gene-deficient mice subjected to NS-CLP compared with the WT NS-CLP group. Furthermore, the IL-17R KO mice subjected to non-severe infection showed a significant increase in serum levels of AST and ALT compared with WT mice subjected to the same procedure (Fig. 4⇓, B and C). These data indicate that the absence of IL-17R signaling leads to diminished recruitment of neutrophils to the infection focus and reduced microbicidal activity of the neutrophils with consequent spread of bacteria infection, which contribute to the development of systemic inflammatory response syndrome and organ injury observed in sepsis.

FIGURE 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 4.

IL-17R signaling is required for the control of systemic inflammatory response. IL-17R KO mice and their respective WT controls were subjected to sham surgery or NS-CLP sepsis induced by the CLP model. A, TNF-α levels in serum were quantified 6 h after sepsis induction. Results are expressed as means ± SEM of five animals per experimental group. ∗, p < 0.05 compared with sham and #, p < 0.05 compared with WT mice subjected to NS-CLP (ANOVA, followed by Bonferroni’s test). The serum levels of AST (B) and ALT (C) were determined 6 h after sepsis induction. The results are expressed as means ± SEM of 10 animals per experimental group. ∗, p < 0.05 compared with sham group and #, p < 0.05 compared with WT mice subjected to NS-CLP (ANOVA followed by Bonferroni’s test).

Cytokine and chemokine production at the infection focus in the absence of IL-17R signaling

To determine whether the reduced neutrophil recruitment to the site of infection observed in IL-17R KO mice subjected to NS-CLP is due to reduced production of chemotactic mediators, we measured the levels of chemotactic cytokines and chemokines in the peritoneal cavity of IL-17R KO and WT mice subjected to NS-CLP. Interestingly, as shown in Fig. 5⇓, the peritoneal exudate concentrations of TNF-α, MIP-2, and KC in IL-17R KO mice subjected to NS-CLP were not lowered compared with WT mice 6 h after sepsis induction. Altogether, these data suggest that the reduction in neutrophil recruitment observed in IL-17R KO mice subjected to non-severe infection is not due to reduced production of TNF-α, MIP-2, or KC at the site of infection.

FIGURE 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 5.

Chemokine and cytokine production in the infection focus in the absence of IL-17R signaling. IL-17R KO mice and their respective WT controls were subjected to sham surgery or NS-CLP sepsis induced by the CLP model. TNF-α, MIP-2, and KC concentrations (pg/ml) were quantified in the peritoneal exudate (A, B, and C, respectively) 6 h after CLP as described in Materials and Methods. The results are expressed as means ± SEM of five animals in each group. ∗, p < 0.05 compared with sham group (ANOVA followed by Bonferroni’s test).

IL-17R-defective mice subjected to non-severe sepsis have fewer circulating leukocytes

Considering the literature data showing that IL-17 up-regulates G-CSF and that overexpression of IL-17 causes neutrophilia in mice (32), we determined the number of circulating neutrophils in IL-17R KO mice subjected to sepsis. It was observed that the baseline numbers of blood-circulating leukocytes and neutrophils were similar in naive IL-17R KO and in WT control mice. However, after the induction of non-severe sepsis, IL-17R-deficient mice had fewer circulating neutrophils compared with WT mice (Table I⇓).

View this table:
  • View inline
  • View popup
Table I.

Number of circulating leukocytes of C57BL/6 (WT) and IL-17R KO mice 6 h after polymicrobial sepsis induced by CLPa

IL-17 induces neutrophil migration to peritoneal cavity and neutrophil chemotaxis

Reinforcing the importance of IL-17A in neutrophil migration, we demonstrated in Fig. 6⇓A that i.p. injection of IL-17A (3–30 ng/cavity) induces significant neutrophil migration to the peritoneal cavity 6 h after cytokine administration. Furthermore, it was also observed that IL-17 induces neutrophil chemotaxis in the Boyden chamber (Fig. 6⇓B). Therefore, the lack of IL-17R signaling may contribute to diminished neutrophil recruitment and lower host resistance to sepsis.

FIGURE 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 6.

IL-17-induces neutrophil migration to peritoneal cavity and neutrophil chemotaxis. A, Neutrophils were harvested from the peritoneal cavity 6 h after the i.p. injection of IL-17 (3, 10, and 30 ng/cavity) or its vehicle (saline, control group; □) in C57BL/6 mice. The results are expressed as the mean ± SEM of five animals per experimental group. ∗, p < 0.05 compared with mice injected with saline (ANOVA, followed by Bonferroni’s test). B, Bone marrow neutrophils from C57BL/6 mice were isolated as described in Materials and Methods. Neutrophil migration in chemotaxis microwell chambers stimulated by 1-h incubation with RPMI 1640 (vehicle; control group) or IL-17 (1–30 ng/ml) was evaluated. ∗, p < 0.05 compared with RPMI 1640 control group (ANOVA followed by Tukey’s test).

Discussion

Neutrophil recruitment to the site of infection is critical for host defense against invading pathogens, especially extracellular bacteria (1, 45). We have shown that the severity of sepsis induced by CLP (4, 5, 8, 12) or Staphylococcus aureus inoculation (6) is closely associated with reduced neutrophil migration to the infection focus. Furthermore, neutrophils from septic patients display a suppressed chemotactic response to fMLP and leukotriene B4, in contrast to neutrophils from healthy controls (13).

To understand the mechanism involved in neutrophil migration to infection focus and consequently in confining the infection locally, we demonstrated in the present study the critical role of IL-17R signaling. IL-17 has been shown to be one of the major cytokines involved in the recruitment of neutrophils in several experimental models of inflammation (35, 46, 47). Our results show that in IL-17R gene-deficient mice marked diminution of neutrophil migration to the infection focus during NS-CLP-induced sepsis and, as a result, had a significantly lower survival rate. In line with these findings, recent studies demonstrated the importance of IL-17R signaling in host defense against infectious microorganisms, such as K. pneumoniae, E. coli, C. albicans, and T. gondii (35, 38, 39, 40). On the other hand, this is in contrast to findings from another study which demonstrated that the blockage of IL-17A protected mice from lethality induced by CLP (41). This inconsistency may be explained by the differences in experimental approaches used: we used IL-17R KO-defective mice, whereas the above-mentioned study used neutralizing mAb against only IL-17A. In our experimental conditions, signaling to IL-17A and IL-17F was absent, since both cytokines bind to IL-17R. IL-17F, a member of the IL-17 family, is the isoform that has the highest degree of homology with IL-17A and has a similar spectrum of activity in terms of mobilizing neutrophils (25). Moreover, both IL-17A and IL-17F induce the production of granulopoietic factors (G-CSF and stem cell factor) and CXC chemokines (26, 33, 36, 48, 49).

We found that the loss of IL-17R signaling during non-severe polymicrobial sepsis results in higher numbers of bacteria in the peritoneal cavity and in blood, confirming that neutrophil migration to the infection focus is a crucial event in controlling and overcoming sepsis. The importance of IL-17 against extracellular bacterial infection was first directly proved in the K. pneumoniae lung infection model. The authors demonstrated that IL-17R-defective mice showed reduced survival after pulmonary K. pneumoniae infection which is associated with increased bacterial number and reduced neutrophil recruitment in the lung (35). Our findings also corroborate another study which demonstrated that impairment of IL-17R signaling results in reduced neutrophil recruitment to the peritoneal cavity after i.p. T. gondii infection with consequent increase in mortality (39). It was recently demonstrated that i.p. or intratracheal administration of IL-17 induces significant neutrophil recruitment, confirming that IL-17 induces neutrophil migration (33, 35). Moreover, it seems that IL-17 is also involved in the neutrophil influx into affected organs during systemic inflammation. In fact, in a recent study, it was demonstrated that the neutrophil accumulation in the small intestine observed in TNF-induced shock is reduced by antiserum against IL-17 or deletion of IL-17R (50). These authors also observed that these treatments increase the survival of the TNF-injected mice, which could appear to be in contradiction with our study. However, it is not the case, since in shock in which an infection focus is absent, as observed with LPS or TNF administration, the inhibition of neutrophil migration to the organs has mainly a beneficial effect because it protects the host organs from injury (51, 52, 53).

Besides neutrophil migration to the infection focus, microbicidal activity of the migrating cells is fundamental to the containment of the infection (54). In this way, it was observed that neutrophils harvested from IL-17R-defective mice already show reduced microbicidal activity compared with WT neutrophils. Furthermore, the microbicidal activity of WT neutrophils was strongly enhanced by IL-17 treatment. Together these results suggest that IL-17R signaling is critical to the microbicidal activity of neutrophils. The potentiating effect of IL-17 on bacterial killing was blunted in neutrophils from IL-17R-defective mice. It argues against a direct killing effect of the cytokine or contaminant present in the cytokine preparation. Our findings corroborate those of others showing that IL-17 potentiates in vitro neutrophil killing of pneumococcus (55). However, they are in apparent contradiction with the demonstration that IL-17 reduces neutrophil antifungal activity (56). The use of different neutrophil microbial targets may explain the observed differences. Furthermore, our data showed that IL-17 effects are mediated by NO. In accordance, other authors demonstrated that IL-17 induces the expression of inducible NO synthase and NO production in various cell types, including endothelial cells, microglia, and chondrocytes (57, 58, 59). In addition, NO is a key mediator of neutrophil microbicidal activity against the majority of pathogens, including Gram-positive and -negative bacteria (2, 3, 60). Additionally, it was recently demonstrated that IL-17 activates macrophage killing of Bortedella pertussis (61). Furthermore, IL-17 also enhances the production of antimicrobial substances, such as β-defensins and the acute phase protein 24p3/lipocalin 2, which exhibit potent antibacterial activities (62, 63). Altogether, this study clearly demonstrates the importance of IL-17 in the protective response against infection.

Sepsis is a systemic inflammatory response resulting from the inability of the host to confine the infection locally. Systemic inflammatory response is considered a central deleterious pathogenic event in sepsis. High levels of serum inflammatory cytokines and chemokines are considered important mediators in the development of lethal multiple organ dysfunction syndrome (64, 65). Consistent with the inability of IL-17R-deficient mice subjected to non-severe sepsis to control infection, these mice showed increased systemic levels of TNF-α and of the enzymes AST and ALT, markers of liver injury.

Recent studies demonstrated that IL-17 induces the release of several inflammatory mediators, including chemokines (e.g., KC, MIP-2, and LIX), which induce neutrophil migration (33, 34, 35, 37). In an apparent contradiction, we found here that the peritoneal exudate concentrations of TNF-α, MIP-2, and KC in IL-17R-defective mice subjected to NS-CLP were not reduced compared with WT mice subjected to the same procedure. The explanation for these divergent findings is that during the sepsis process, besides IL-17 production, other mediators are produced, such as TNF-α and IL-1β (4, 8), and they also stimulate chemokine production (66, 67, 68).

Taking into account that in our study the levels of cytokines and chemokines at the infection site of IL-17R KO mice were not reduced, we decided to investigate why the IL-17R KO mice showed reduced neutrophil migration to the infection focus. Accordingly, we showed that i.p. injection of IL-17 induces neutrophil migration to the peritoneal cavity of mice and, interestingly, we demonstrated a direct effect of IL-17 in which it induced neutrophil chemotaxis in the Boyden chamber. These results suggest that although cytokines and chemokines released by an IL-17R-independent mechanism could contribute to neutrophil migration, IL-17R signaling could be critical to neutrophil recruitment to the infection focus.

The literature data demonstrate that IL-17 also stimulates hematopoiesis, particularly granulopoiesis (69), partly due to the stimulation of G-CSF and the transmembrane form of stem cell factor (70). The present study shows that IL-17R-deficient mice possess less ability to recruit neutrophils into the circulation after the induction of sepsis. In accordance, Tan et al. (71) demonstrated that mice with homozygous deletions of IL-17R have normal circulating numbers of neutrophils, but are much more susceptible to sublethal γ irradiation and show reduced neutrophil recovery. These data suggest that stress-induced granulopoiesis requires IL-17R signaling (71). Furthermore, another study showed that the number of blood neutrophils in IL-17R KO mice is significantly reduced compared with control WT mice after infection with K. pneumonia, demonstrating that these mice have defective granulopoiesis in response to infection (35). Altogether, our results suggest that the reduction in neutrophil recruitment observed in IL-17R KO mice subjected to non-severe sepsis can also be, at least in part, due to the reduced number of circulating neutrophils.

In summary, we demonstrated a critical role of IL-17R signaling in the outcome of sepsis. We showed that IL-17R gene-deficient mice subjected to non-severe sepsis have reduced neutrophil recruitment to the infection focus, dissemination of infection, and increase in systemic inflammatory response with consequent increase in mortality rate. Finally, it was demonstrated that IL-17 increases neutrophil killing capacity and induces neutrophil migration in vivo and in vitro. Therefore, the data suggest that IL-17 contributes to host protection against sepsis.

Acknowledgments

We are grateful to Analbery Monteiro and Giuliana Bertozi Francisco for excellent assistance. Dr. A. Leyva provided English editing of this manuscript.

Disclosures

The authors have no financial conflict of interest.

Footnotes

  • The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • ↵1 This work was supported by Fundação de Amparo à Pesquisa do Estado de São Paulo and Conselho Nacional de Pesquisa e Desenvolvimento Tecnológico.

  • ↵2 Address correspondence and reprint requests to Prof. Fernando de Queiróz Cunha. Department of Pharmacology, School of Medicine of Ribeirão Preto, Avenida Bandeirantes, 3900, 14049-900-Ribeirão Preto, São Paulo, Brazil and Dr. Bernhard Ryffel, UMR6218, IEM, CNRS Transgenose Institute, 45071 Orleans, France. E-mail addresses: fdqcunha{at}fmrp.usp.br and bryffel{at}cnrs-orleans.fr

  • ↵3 Abbreviations used in this paper: KC, keratinocyte-derived chemokine; BHI, brain-heart infusion; CLP, cecal ligation and puncture; NS-CLP, non-severe septic injury; S-CLP, severe septic injury; WT, wild type; KO, knockout; AG, aminoguanidine; AST, aspartate aminotransferase; ALT, alanine aminotransferase.

  • Received September 16, 2008.
  • Accepted April 6, 2009.
  • Copyright © 2009 by The American Association of Immunologists, Inc.

References

  1. ↵
    Segal, A. W.. 2005. How neutrophils kill microbes. Annu. Rev. Immunol. 23: 197-223.
    OpenUrlCrossRefPubMed
  2. ↵
    Malawista, S. E., R. R. Montgomery, G. van Blaricom. 1992. Evidence for reactive nitrogen intermediates in killing of staphylococci by human neutrophil cytoplasts: a new microbicidal pathway for polymorphonuclear leukocytes. J. Clin. Invest. 90: 631-636.
    OpenUrlCrossRefPubMed
  3. ↵
    Fierro, I. M., V. Nascimento-DaSilva, M. A. Arruda, M. S. Freitas, M. C. Plotkowski, F. Q. Cunha, C. Barja-Fidalgo. 1999. Induction of NOS in rat blood PMN in vivo and in vitro: modulation by tyrosine kinase and involvement in bactericidal activity. J. Leukocyte Biol. 65: 508-514.
    OpenUrlAbstract
  4. ↵
    Benjamim, C. F., S. H. Ferreira, F. Q. Cunha. 2000. Role of nitric oxide in the failure of neutrophil migration in sepsis. J. Infect. Dis. 182: 214-223.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Benjamim, C. F., J. S. Silva, Z. B. Fortes, M. A. Oliveira, S. H. Ferreira, F. Q. Cunha. 2002. Inhibition of leukocyte rolling by nitric oxide during sepsis leads to reduced migration of active microbicidal neutrophils. Infect. Immun. 70: 3602-3610.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Crosara-Alberto, D. P., A. L. Darini, R. Y. Inoue, J. S. Silva, S. H. Ferreira, F. Q. Cunha. 2002. Involvement of NO in the failure of neutrophil migration in sepsis induced by Staphylococcus aureus. Br. J. Pharmacol. 136: 645-658.
    OpenUrlCrossRefPubMed
  7. ↵
    Carvalho, M., C. Benjamim, F. Santos, S. Ferreira, F. Cunha. 2005. Effect of mast cells depletion on the failure of neutrophil migration during sepsis. Eur. J Pharmacol. 525: 161-169.
    OpenUrlCrossRefPubMed
  8. ↵
    Alves-Filho, J. C., A. de Freitas, M. Russo, F. Q. Cunha. 2006. Toll-like receptor 4 signaling leads to neutrophil migration impairment in polymicrobial sepsis. Crit. Care Med. 34: 461-470.
    OpenUrlCrossRefPubMed
  9. ↵
    Igonin, A. A., V. W. Armstrong, M. Shipkova, N. B. Lazareva, V. G. Kukes, M. Oellerich. 2004. Circulating cytokines as markers of systemic inflammatory response in severe community-acquired pneumonia. Clin. Biochem. 37: 204-209.
    OpenUrlCrossRefPubMed
  10. ↵
    Candel, F. J., E. Grima, M. Matesanz, C. Cervera, G. Soto, M. Almela, J. A. Martinez, M. Navasa, F. Cofan, M. J. Ricart, F. Perez-Villa, A. Moreno. 2005. Bacteremia and septic shock after solid-organ transplantation. Transplant. Proc. 37: 4097-4099.
    OpenUrlCrossRefPubMed
  11. ↵
    Tsiotou, A. G., G. H. Sakorafas, G. Anagnostopoulos, J. Bramis. 2005. Septic shock; current pathogenetic concepts from a clinical perspective. Med. Sci. Monit. 11: RA76-RA85.
    OpenUrlPubMed
  12. ↵
    Torres-Duenas, D., M. R. Celes, A. Freitas, J. C. Alves-Filho, F. Spiller, D. Dal-Secco, V. F. Dalto, M. A. Rossi, S. H. Ferreira, F. Q. Cunha. 2007. Peroxynitrite mediates the failure of neutrophil migration in severe polymicrobial sepsis in mice. Br. J. Pharmacol. 152: 341-352.
    OpenUrlCrossRefPubMed
  13. ↵
    Tavares-Murta, B. M., M. Zaparoli, R. B. Ferreira, M. L. Silva-Vergara, C. H. Oliveira, E. F. Murta, S. H. Ferreira, F. Q. Cunha. 2002. Failure of neutrophil chemotactic function in septic patients. Crit. Care Med. 30: 1056-1061.
    OpenUrlCrossRefPubMed
  14. ↵
    Arraes, S. M., M. S. Freitas, S. V. da Silva, H. A. de Paula Neto, J. C. Alves-Filho, M. Auxiliadora Martins, A. Basile-Filho, B. M. Tavares-Murta, C. Barja-Fidalgo, F. Q. Cunha. 2006. Impaired neutrophil chemotaxis in sepsis associates with GRK expression and inhibition of actin assembly and tyrosine phosphorylation. Blood 108: 2906-2913.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    Tavares-Murta, B. M., F. Q. Cunha, S. H. Ferreira. 1998. The intravenous administration of tumor necrosis factor α, interleukin 8 and macrophage-derived neutrophil chemotactic factor inhibits neutrophil migration by stimulating nitric oxide production. Br. J. Pharmacol. 124: 1369-1374.
    OpenUrlCrossRefPubMed
  16. ↵
    Tavares-Murta, B. M., J. S. Machado, S. H. Ferreira, F. Q. Cunha. 2001. Nitric oxide mediates the inhibition of neutrophil migration induced by systemic administration of LPS. Inflammation 25: 247-253.
    OpenUrlCrossRefPubMed
  17. ↵
    Rios-Santos, F., J. C. Alves-Filho, F. O. Souto, F. Spiller, A. Freitas, C. M. Lotufo, M. B. Soares, R. R. Dos Santos, M. M. Teixeira, F. Q. Cunha. 2007. Down-regulation of CXCR2 on neutrophils in severe sepsis is mediated by inducible nitric oxide synthase-derived nitric oxide. Am. J. Respir. Crit. Care Med. 175: 490-497.
    OpenUrlCrossRefPubMed
  18. ↵
    Yao, Z., S. L. Painter, W. C. Fanslow, D. Ulrich, B. M. Macduff, M. K. Spriggs, R. J. Armitage. 1995. Human IL-17: a novel cytokine derived from T cells. J. Immunol. 155: 5483-5486.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    Li, H., J. Chen, A. Huang, J. Stinson, S. Heldens, J. Foster, P. Dowd, A. L. Gurney, W. I. Wood. 2000. Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family. Proc. Natl. Acad. Sci. USA 97: 773-778.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    Lee, J., W. H. Ho, M. Maruoka, R. T. Corpuz, D. T. Baldwin, J. S. Foster, A. D. Goddard, D. G. Yansura, R. L. Vandlen, W. I. Wood, A. L. Gurney. 2001. IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1. J. Biol. Chem. 276: 1660-1664.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    Starnes, T., M. J. Robertson, G. Sledge, S. Kelich, H. Nakshatri, H. E. Broxmeyer, R. Hromas. 2001. Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. J. Immunol. 167: 4137-4140.
    OpenUrlAbstract/FREE Full Text
  22. ↵
    Hymowitz, S. G., E. H. Filvaroff, J. P. Yin, J. Lee, L. Cai, P. Risser, M. Maruoka, W. Mao, J. Foster, R. F. Kelley, et al 2001. IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J. 20: 5332-5341.
    OpenUrlAbstract
  23. ↵
    Starnes, T., H. E. Broxmeyer, M. J. Robertson, R. Hromas. 2002. Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis. J. Immunol. 169: 642-646.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Aggarwal, S., A. L. Gurney. 2002. IL-17: prototype member of an emerging cytokine family. J. Leukocyte Biol. 71: 1-8.
    OpenUrlAbstract/FREE Full Text
  25. ↵
    Hurst, S. D., T. Muchamuel, D. M. Gorman, J. M. Gilbert, T. Clifford, S. Kwan, S. Menon, B. Seymour, C. Jackson, T. T. Kung, et al 2002. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J. Immunol. 169: 443-453.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    Fossiez, F., J. Banchereau, R. Murray, C. Van Kooten, P. Garrone, S. Lebecque. 1998. Interleukin-17. Int. Rev. Immunol. 16: 541-551.
    OpenUrlCrossRefPubMed
  27. ↵
    Ferretti, S., O. Bonneau, G. R. Dubois, C. E. Jones, A. Trifilieff. 2003. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J. Immunol. 170: 2106-2112.
    OpenUrlAbstract/FREE Full Text
  28. ↵
    Moseley, T. A., D. R. Haudenschild, L. Rose, A. H. Reddi. 2003. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev. 14: 155-174.
    OpenUrlCrossRefPubMed
  29. ↵
    Witowski, J., K. Ksiazek, A. Jorres. 2004. Interleukin-17: a mediator of inflammatory responses. Cell. Mol. Life Sci. 61: 567-579.
    OpenUrlCrossRefPubMed
  30. ↵
    Harrington, L. E., R. D. Hatton, P. R. Mangan, H. Turner, T. L. Murphy, K. M. Murphy, C. T. Weaver. 2005. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6: 1123-1132.
    OpenUrlCrossRefPubMed
  31. ↵
    Park, H., Z. Li, X. O. Yang, S. H. Chang, R. Nurieva, Y. H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian, C. Dong. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6: 1133-1141.
    OpenUrlCrossRefPubMed
  32. ↵
    Schwarzenberger, P., J. K. Kolls. 2002. Interleukin 17: an example for gene therapy as a tool to study cytokine mediated regulation of hematopoiesis. J. Cell Biochem. Suppl. 38: 88-95.
    OpenUrlPubMed
  33. ↵
    Laan, M., Z. H. Cui, H. Hoshino, J. Lotvall, M. Sjostrand, D. C. Gruenert, B. E. Skoogh, A. Linden. 1999. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J. Immunol. 162: 2347-2352.
    OpenUrlAbstract/FREE Full Text
  34. ↵
    Witowski, J., K. Pawlaczyk, A. Breborowicz, A. Scheuren, M. Kuzlan-Pawlaczyk, J. Wisniewska, A. Polubinska, H. Friess, G. M. Gahl, U. Frei, A. Jorres. 2000. IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GROα chemokine from mesothelial cells. J. Immunol. 165: 5814-5821.
    OpenUrlAbstract/FREE Full Text
  35. ↵
    Ye, P., F. H. Rodriguez, S. Kanaly, K. L. Stocking, J. Schurr, P. Schwarzenberger, P. Oliver, W. Huang, P. Zhang, J. Zhang, et al 2001. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 194: 519-527.
    OpenUrlAbstract/FREE Full Text
  36. ↵
    Kawaguchi, M., F. Kokubu, S. Matsukura, K. Ieki, M. Odaka, S. Watanabe, S. Suzuki, M. Adachi, S. K. Huang. 2003. Induction of C-X-C chemokines, growth-related oncogene α expression, and epithelial cell-derived neutrophil-activating protein-78 by ML-1 (interleukin-17F) involves activation of Raf1-mitogen-activated protein kinase kinase-extracellular signal-regulated kinase 1/2 pathway. J. Pharmacol. Exp. Ther. 307: 1213-1220.
    OpenUrlAbstract/FREE Full Text
  37. ↵
    Kolls, J. K., A. Linden. 2004. Interleukin-17 family members and inflammation. Immunity 21: 467-476.
    OpenUrlCrossRefPubMed
  38. ↵
    Huang, W., L. Na, P. L. Fidel, P. Schwarzenberger. 2004. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J. Infect. Dis. 190: 624-631.
    OpenUrlAbstract/FREE Full Text
  39. ↵
    Kelly, M. N., J. K. Kolls, K. Happel, J. D. Schwartzman, P. Schwarzenberger, C. Combe, M. Moretto, I. A. Khan. 2005. Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection. Infect. Immun. 73: 617-621.
    OpenUrlAbstract/FREE Full Text
  40. ↵
    Shibata, K., H. Yamada, H. Hara, K. Kishihara, Y. Yoshikai. 2007. Resident Vδ1+ γδ T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J. Immunol. 178: 4466-4472.
    OpenUrlAbstract/FREE Full Text
  41. ↵
    Flierl, M. A., D. Rittirsch, H. Gao, L. M. Hoesel, B. A. Nadeau, D. E. Day, F. S. Zetoune, J. V. Sarma, M. S. Huber-Lang, J. L. Ferrara, P. A. Ward. 2008. Adverse functions of IL-17A in experimental sepsis. FASEB J. 22: 2198-2205.
    OpenUrlAbstract/FREE Full Text
  42. ↵
    Wichterman, K. A., A. E. Baue, I. H. Chaudry. 1980. Sepsis and septic shock: a review of laboratory models and a proposal. J. Surg. Res. 29: 189-201.
    OpenUrlCrossRefPubMed
  43. ↵
    Godshall, C. J., M. J. Scott, J. C. Peyton, S. A. Gardner, W. G. Cheadle. 2002. Genetic background determines susceptibility during murine septic peritonitis. J. Surg. Res. 102: 45-49.
    OpenUrlCrossRefPubMed
  44. ↵
    Pinho, V., R. de Castro Russo, F. A. Amaral, L. P. de Sousa, M. M. Barsante, D. G. de Souza, J. C. Alves-Filho, D. C. Cara, J. S. Hayflick, C. Rommel, et al 2007. Tissue- and stimulus-dependent role of phosphatidylinositol 3-kinase isoforms for neutrophil recruitment induced by chemoattractants in vivo. J. Immunol. 179: 7891-7898.
    OpenUrlAbstract/FREE Full Text
  45. ↵
    Bokoch, G. M.. 1995. Chemoattractant signaling and leukocyte activation. Blood 86: 1649-1660.
    OpenUrlFREE Full Text
  46. ↵
    Lubberts, E., L. A. Joosten, B. Oppers, L. van den Bersselaar, C. J. Coenen-de Roo, J. K. Kolls, P. Schwarzenberger, F. A. van de Loo, W. B. van den Berg. 2001. IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis. J. Immunol. 167: 1004-1013.
    OpenUrlAbstract/FREE Full Text
  47. ↵
    Molesworth-Kenyon, S. J., R. Yin, J. E. Oakes, R. N. Lausch. 2008. IL-17 receptor signaling influences virus-induced corneal inflammation. J. Leukocyte Biol. 83: 401-408.
    OpenUrlAbstract/FREE Full Text
  48. ↵
    Laan, M., J. Lotvall, K. F. Chung, A. Linden. 2001. IL-17-induced cytokine release in human bronchial epithelial cells in vitro: role of mitogen-activated protein (MAP) kinases. Br. J. Pharmacol. 133: 200-206.
    OpenUrlCrossRefPubMed
  49. ↵
    Jones, C. E., K. Chan. 2002. Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-α, and granulocyte-colony-stimulating factor by human airway epithelial cells. Am. J. Respir. Cell. Mol. Biol. 26: 748-753.
    OpenUrlCrossRefPubMed
  50. ↵
    Takahashi, N., I. Vanlaere, R. de Rycke, A. Cauwels, L. A. Joosten, E. Lubberts, W. B. van den Berg, C. Libert. 2008. IL-17 produced by Paneth cells drives TNF-induced shock. J. Exp. Med. 205: 1755-1761.
    OpenUrlAbstract/FREE Full Text
  51. ↵
    Carden, D. L., D. N. Granger. 2000. Pathophysiology of ischaemia-reperfusion injury. J. Pathol. 190: 255-266.
    OpenUrlCrossRefPubMed
  52. ↵
    Doerschuk, C. M.. 2001. Mechanisms of leukocyte sequestration in inflamed lungs. Microcirculation 8: 71-88.
    OpenUrlCrossRefPubMed
  53. ↵
    Chin, A. C., C. A. Parkos. 2007. Pathobiology of neutrophil transepithelial migration: implications in mediating epithelial injury. Annu. Rev. Pathol. 2: 111-143.
    OpenUrlCrossRefPubMed
  54. ↵
    Baker, C. C., M. D. Huynh. 1995. Sepsis in the critically ill patient. Curr. Probl. Surg. 32: 1013-1083.
    OpenUrlCrossRefPubMed
  55. ↵
    Lu, Y. J., J. Gross, D. Bogaert, A. Finn, L. Bagrade, Q. Zhang, J. K. Kolls, A. Srivastava, A. Lundgren, S. Forte, et al 2008. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog. 4: e1000159
    OpenUrlCrossRefPubMed
  56. ↵
    Zelante, T., A. De Luca, P. Bonifazi, C. Montagnoli, S. Bozza, S. Moretti, M. L. Belladonna, C. Vacca, C. Conte, P. Mosci, et al 2007. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur. J. Immunol. 37: 2695-2706.
    OpenUrlCrossRefPubMed
  57. ↵
    Shalom-Barak, T., J. Quach, M. Lotz. 1998. Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-κB. J. Biol. Chem. 273: 27467-27473.
    OpenUrlAbstract/FREE Full Text
  58. ↵
    Miljkovic, D., I. Cvetkovic, O. Vuckovic, S. Stosic-Grujicic, M. Mostarica Stojkovic, V. Trajkovic. 2003. The role of interleukin-17 in inducible nitric oxide synthase-mediated nitric oxide production in endothelial cells. Cell. Mol. Life Sci. 60: 518-525.
    OpenUrlCrossRefPubMed
  59. ↵
    Kawanokuchi, J., K. Shimizu, A. Nitta, K. Yamada, T. Mizuno, H. Takeuchi, A. Suzumura. 2008. Production and functions of IL-17 in microglia. J. Neuroimmunol. 194: 54-61.
    OpenUrlCrossRefPubMed
  60. ↵
    Kaplan, S. S., J. R. Lancaster, Jr, R. E. Basford, R. L. Simmons. 1996. Effect of nitric oxide on staphylococcal killing and interactive effect with superoxide. Infect. Immun. 64: 69-76.
    OpenUrlAbstract/FREE Full Text
  61. ↵
    Higgins, S. C., A. G. Jarnicki, E. C. Lavelle, K. H. Mills. 2006. TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells. J. Immunol. 177: 7980-7989.
    OpenUrlAbstract/FREE Full Text
  62. ↵
    Kao, C. Y., Y. Chen, P. Thai, S. Wachi, F. Huang, C. Kim, R. W. Harper, R. Wu. 2004. IL-17 markedly up-regulates β-defensin-2 expression in human airway epithelium via JAK and NF-κB signaling pathways. J. Immunol. 173: 3482-3491.
    OpenUrlAbstract/FREE Full Text
  63. ↵
    Shen, F., Z. Hu, J. Goswami, S. L. Gaffen. 2006. Identification of common transcriptional regulatory elements in interleukin-17 target genes. J. Biol. Chem. 281: 24138-24148.
    OpenUrlAbstract/FREE Full Text
  64. ↵
    Walley, K. R., N. W. Lukacs, T. J. Standiford, R. M. Strieter, S. L. Kunkel. 1996. Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect. Immun. 64: 4733-4738.
    OpenUrlAbstract/FREE Full Text
  65. ↵
    Hotchkiss, R. S., I. E. Karl. 2003. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348: 138-150.
    OpenUrlCrossRefPubMed
  66. ↵
    Wagner, J. G., R. A. Roth. 2000. Neutrophil migration mechanisms, with an emphasis on the pulmonary vasculature. Pharmacol. Rev. 52: 349-374.
    OpenUrlAbstract/FREE Full Text
  67. ↵
    Jordan, N. J., M. L. Watson, J. Westwick. 1995. The protein phosphatase inhibitor calyculin A stimulates chemokine production by human synovial cells. Biochem. J. 311: 89-95.
    OpenUrlPubMed
  68. ↵
    Grespan, R., S. Y. Fukada, H. P. Lemos, S. M. Vieira, M. H. Napimoga, M. M. Teixeira, A. R. Fraser, F. Y. Liew, I. B. McInnes, F. Q. Cunha. 2008. CXCR2-specific chemokines mediate leukotriene B4-dependent recruitment of neutrophils to inflamed joints in mice with antigen-induced arthritis. Arthritis Rheum. 58: 2030-2040.
    OpenUrlCrossRefPubMed
  69. ↵
    Schwarzenberger, P., V. La Russa, A. Miller, P. Ye, W. Huang, A. Zieske, S. Nelson, G. J. Bagby, D. Stoltz, R. L. Mynatt, et al 1998. IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. J. Immunol. 161: 6383-6389.
    OpenUrlAbstract/FREE Full Text
  70. ↵
    Schwarzenberger, P., W. Huang, P. Ye, P. Oliver, M. Manuel, Z. Zhang, G. Bagby, S. Nelson, J. K. Kolls. 2000. Requirement of endogenous stem cell factor and granulocyte-colony-stimulating factor for IL-17-mediated granulopoiesis. J. Immunol. 164: 4783-4789.
    OpenUrlAbstract/FREE Full Text
  71. ↵
    Tan, W., W. Huang, Q. Zhong, P. Schwarzenberger. 2006. IL-17 receptor knockout mice have enhanced myelotoxicity and impaired hemopoietic recovery following γ irradiation. J. Immunol. 176: 6186-6193.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

The Journal of Immunology: 182 (12)
The Journal of Immunology
Vol. 182, Issue 12
15 Jun 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Advertising (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
IL-17 Receptor Signaling Is Required to Control Polymicrobial Sepsis
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
IL-17 Receptor Signaling Is Required to Control Polymicrobial Sepsis
Andressa Freitas, José C. Alves-Filho, Tatiana Victoni, Thomas Secher, Henrique P. Lemos, Fabiane Sônego, Fernando Q. Cunha, Bernhard Ryffel
The Journal of Immunology June 15, 2009, 182 (12) 7846-7854; DOI: 10.4049/jimmunol.0803039

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
IL-17 Receptor Signaling Is Required to Control Polymicrobial Sepsis
Andressa Freitas, José C. Alves-Filho, Tatiana Victoni, Thomas Secher, Henrique P. Lemos, Fabiane Sônego, Fernando Q. Cunha, Bernhard Ryffel
The Journal of Immunology June 15, 2009, 182 (12) 7846-7854; DOI: 10.4049/jimmunol.0803039
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Disclosures
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Early Self-Regulatory Mechanisms Control the Magnitude of CD8+ T Cell Responses Against Liver Stages of Murine Malaria
  • Sublethal Hyperoxia Impairs Pulmonary Innate Immunity
  • Dependence of IL-4, IL-13, and Nematode-Induced Alterations in Murine Small Intestinal Smooth Muscle Contractility on Stat6 and Enteric Nerves
Show more HOST DEFENSE

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • Public Access
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606